Phase II Multicenter Clinical Trial of Pulmonary Metastasectomy and Isolated Lung Perfusion with Melphalan in Patients with Resectable Lung Metastases

Author(s):
Hengst, W.A. den; Hendriks, J.M.H.; Balduyck, B.; Rodrigus, I.; Vermorken, J.B.; Lardon, F.; Versteegh, M.I.M.; Braun, J.; Gelderblom, H.; Schramel, F.M.N.H.; ; Putte, B.P. van; Birim, O.; Maat, A.P.W.M.; Schil, P.E.Y. van
Published
2014
Publication type
Article / Letter to editor
Isolated lung perfusionLocal controlLung metastasesSurvivalCombined modality treatment
Date issued
2014-10-31
Language
English
Is part of
Journal of Thoracic Oncology (2014), Vol. 9, no. 10, p. 1547-1553
hdl
1887/103049
doi
10.1097/JTO.0000000000000279